These final results, together with a earlier report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assist the concept of targeting ACKR3 as a unique method to modulate the opioid program, which could open new therapeutic avenues for opioid-similar Issues. At that time, Microsoft Advertising https://cassa297meu4.wikiparticularization.com/user